These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23037740)

  • 1. [Standard therapy for multiple myeloma].
    Tokuhira M; Kizaki M
    Rinsho Ketsueki; 2012 Oct; 53(10):1675-88. PubMed ID: 23037740
    [No Abstract]   [Full Text] [Related]  

  • 2. Supportive therapies in the management of myeloma.
    Ludwig H;
    Oncology (Williston Park); 2004 Mar; 18(3):295-6, 298. PubMed ID: 15065700
    [No Abstract]   [Full Text] [Related]  

  • 3. Myeloma--new approaches to combined nephrological-haematological management.
    Haubitz M; Peest D
    Nephrol Dial Transplant; 2006 Mar; 21(3):582-90. PubMed ID: 16396976
    [No Abstract]   [Full Text] [Related]  

  • 4. The evolution and impact of therapy in multiple myeloma.
    Laubach JP; Richardson PG; Anderson KC
    Med Oncol; 2010 Jun; 27 Suppl 1():S1-6. PubMed ID: 20169425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma. Progress is being made.
    Mayo Clin Health Lett; 2011 Mar; 29(3):4-5. PubMed ID: 21553706
    [No Abstract]   [Full Text] [Related]  

  • 6. What did we learn in 2010 from the phase III trials? Is maintenance therapy the new standard for myeloma?
    Giralt S; Stadtmauer E; McCarthy P
    Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S30-2. PubMed ID: 21195307
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation and monitoring of response to therapy in multiple myeloma.
    Rajkumar SV; Dispenzieri A
    Haematologica; 2005 Oct; 90(10):1305-8. PubMed ID: 16219565
    [No Abstract]   [Full Text] [Related]  

  • 8. Stem cell transplant for first relapse from the multiple myeloma research foundation.
    Anderson KC; Vesole DH
    Oncology (Williston Park); 2006 Dec; 20(14):1818, 1820-1, 1825-6. PubMed ID: 17263130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloma (multiple).
    Kumar A; Djulbegovic B
    Clin Evid; 2006 Jun; (15):1-29. PubMed ID: 16973003
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.
    Tariman JD; Estrella SM
    Oncol Nurs Forum; 2005 Nov; 32(6):E127-38. PubMed ID: 16270103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current perspectives in the treatment of multiple myeloma - news and views].
    Knop S
    Dtsch Med Wochenschr; 2012 Mar; 137(13):636-9. PubMed ID: 22434170
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple myeloma - current issues and controversies.
    Kumar S
    Cancer Treat Rev; 2010 May; 36 Suppl 2():S3-11. PubMed ID: 20472186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma.
    Kyle RA; Rajkumar SV
    N Engl J Med; 2004 Oct; 351(18):1860-73. PubMed ID: 15509819
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastric relapse of plasma-cell myeloma after stem-cell transplantation.
    Pollheimer VS; Pollheimer MJ; Eherer AJ; Langner C
    Gastrointest Endosc; 2007 Jul; 66(1):179-80; discussion 180. PubMed ID: 17451699
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autologous stem cell transplantation in multiple myeloma - pro].
    Goldschmidt H
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1942. PubMed ID: 19760555
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of high-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.
    Hussein M
    Leukemia; 2004 Apr; 18(4):893. PubMed ID: 14973496
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of myeloma: cure vs control.
    Rajkumar SV
    Mayo Clin Proc; 2008 Oct; 83(10):1142-5. PubMed ID: 18828974
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials referral resource. Current clinical trials in multiple myeloma.
    Davis T; Schoenfeldt M
    Oncology (Williston Park); 2004 Feb; 18(2):196-8, 203. PubMed ID: 15008057
    [No Abstract]   [Full Text] [Related]  

  • 19. Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival.
    Jimenez-Zepeda VH; Mikhael J; Winter A; Franke N; Masih-Khan E; Trudel S; Chen C; Kukreti V; Reece DE
    Biol Blood Marrow Transplant; 2012 May; 18(5):773-9. PubMed ID: 22062804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma.
    Patriarca F; Sperotto A; Filì C; Zaja F; Prosdocimo S; Fanin R
    Haematologica; 2002 Jul; 87(7):779-81. PubMed ID: 12091134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.